HELX ETF

HELX ETF
$39.77
See how much of HELX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Nov 3, 2026

Net Assets
$34M
Expense Ratio
0.50%
Dividend Yield (Current)
-
Holdings
71
Inception Date
Feb 25, 2020
Fund Family
Franklin Templeton Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+23.97%
1 Year+28.98%
3 Year+21.27%
5 Year-3.09%

Asset Allocation

Stocks: 99.94%
Cash: 0.10%
See how much of HELX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NTRANatera Inc9.59%
GHGuardant Health, Inc9.52%
KRYSKrystal Biotech Inc4.66%
LGNDLigand Pharmaceuticals Inc4.48%
ADPTAdaptive Biotechnologies Corp4.31%
Top 10 Concentration: 47.80%Report Date: Nov 3, 2026
Download all 71 holdings for HELX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$0.00
Dec 30, 2024

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

HELX ETF Overview

HELX ETF (Franklin Genomic Advancements ETF) is managed by Franklin Templeton Investments (US) with $34.0M in net assets. HELX expense ratio is 0.50%, holding 71 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2020-02-25.

HELX performance shows a YTD return of 23.97%. The 1-year return is 28.98% and the 5-year return is -3.09%.

HELX top holdings include Natera Inc (9.6%), Guardant Health, Inc (9.5%), Krystal Biotech Inc (4.7%), Ligand Pharmaceuticals Inc (4.5%), Adaptive Biotechnologies Corp (4.3%). Go to all HELX holdings, HELX sectors, or HELX dividends.

HELX can be compared against other funds. Use HELX overlap to find shared positions, or HELX vs another fund for a side-by-side view. HELX alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+1.73%
YTD
+23.97%
1 Year
+28.98%
3 Year
+21.27%

Top 10 Holdings (47.8% of portfolio)

#TickerNameSectorWeight
1NTRANatera IncHealth Care9.59%
2GHGuardant Health, IncHealth Care9.52%
3KRYSKrystal Biotech IncHealth Care4.66%
4LGNDLigand Pharmaceuticals IncHealth Care4.48%
5ADPTAdaptive Biotechnologies CorpHealth Care4.31%
6TWSTTwist Bioscience CorpHealth Care3.82%
7BBIOBridgeBio Pharma IncHealth Care3.12%
8MEDPMedpace Holdings IncHealth Care2.82%
9UTHRUnited Therapeutics CorpHealth Care2.76%
10LLYEli Lilly & CoHealth Care2.72%